Praxis Precision Medicines annual operating margin
2023
2024
Praxis Precision Medicines's operating margin was −2,340.29% for fiscal 2024.
View full Praxis Precision Medicines company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2024 | 2024-12-31 | −2,340.29% | +2824.12 pp |
| 2023 | 2023-12-31 | −5,164.41% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q4 2024 | 2024-12-31 | −856.97% | +4542.25 pp |
| Q3 2024 | 2024-09-30 | −18,819.54% | −13367.40 pp |
| Q2 2024 | 2024-06-30 | −10,500.84% | −6024.53 pp |
| Q1 2024 | 2024-03-31 | −9,718.33% | −4141.32 pp |
| Q4 2023 | 2023-12-31 | −5,399.22% | — |
| Q3 2023 | 2023-09-30 | −5,452.14% | — |
| Q2 2023 | 2023-06-30 | −4,476.31% | — |
| Q1 2023 | 2023-03-31 | −5,577.01% | — |
Across the available reported history, Praxis Precision Medicines's operating margin increased from −5,164.41% to −2,340.29%, a change of +2824.12 percentage points. The latest reported quarter, Q4 2024, shows −856.97%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Praxis Precision Medicines filings at SEC.gov ↗